Study Questions FDA Approvals of Cardiac Devices

admin | December 30, 2009

Study Questions FDA Approvals of Cardiac Devices
By Amanda Gardner
HealthDay Reporter

TUESDAY, Dec. 29 (HealthDay News) — The U.S. Food and Drug Administration may not be as stringent in evaluating devices as it is in approving drugs.

According to a report in the Dec. 23/30 issue of the Journal of the American Medical Association, approval of cardiovascular devices often sails through based on studies that are not randomized or blinded, and sometimes even on the basis of one study alone.

Dec 21, 4:00 PM ESTStudy: Sticking with heart rehab boosts survival

admin | December 23, 2009

If you’ve had a heart attack or a bypass operation, there’s an easy way to help prevent another one: stick with rehab.

People who get all 36 sessions of cardiac rehabilitation that most Medicare plans cover are less likely to die or suffer a heart attack in the next three to four years than people who have fewer sessions, a new study finds.

The research could encourage the multitudes of heart patients who don’t follow doctors’ orders to heed their advice. Only about one-fifth of heart patients even try rehab. Of those who do, few get all the sessions that are recommended.

The Cost Conundrum

admin | December 21, 2009

It is spring in McAllen, Texas. The morning sun is warm. The streets are lined with palm trees and pickup trucks. McAllen is in Hidalgo County, which has the lowest household income in the country, but it’s a border town, and a thriving foreign-trade zone has kept the unemployment rate below ten per cent. McAllen calls itself the Square Dance Capital of the World. “Lonesome Dove” was set around here.

A Prescription For The Health Care Crisis

admin | December 21, 2009

With all the shouting going on about America’s health care crisis, many are probably finding it difficult to concentrate, much less understand the cause of the problems confronting us. I find myself dismayed at the tone of the discussion (though I understand it—people are scared) as well as bemused that anyone would presume themselves sufficiently qualified to know how to best improve our health care system simply because they’ve encountered it, when people who’ve spent entire careers studying it (and I don’t mean politicians) aren’t sure what to do themselves.

Heart Disease to Cost U.S $503 Billion in 2010: Group

admin | December 18, 2009

WASHINGTON (Reuters) - Cardiovascular disease and stroke will cost the United States an estimated $503.2 billion in 2010, an increase of nearly 6 percent, and many cases could have been prevented, the American Heart Association said on Thursday.

The figure includes both health care costs and lost productivity due to death and disease, according to an update published online in the journal Circulation.

The heart association says obesity and other risk factors, like too little exercise and poor diet, are fueling the expected increase in health care costs associated with heart disease and stroke.

Shaking Up Heart Disease with EECP Therapy

admin | December 17, 2009

Wednesday, December 16, 2009

Shaking Up Heart Disease with EECP Therapy

Shaking Up Heart Disease - Non-Surgical Treatment Strengthens The Heart
Enhanced External Counterpulsation (EEC), is a non-invasive therapy.

A series of inflatable cuffs placed around the legs and attached to a computer forces blood into the heart between each beat.

Enhanced External Counterpulsation (EECP), is an FDA cleared, non-surgical treatment option for individuals who experience symptoms from cardiovascular disease. It helps increase the flow of blood to your heart. EECP is FDA approved, covered by Medicare and clinical studies have shown 85% of patients treated with EECP® experience a reduction in angina and are able to return to a more active lifestyle.

Myocardial infarction related to coronary artery bypass

admin | December 10, 2009

Br Heart J 1984; 51: 399-406
Myocardial infarction related to coronary artery bypass
graft surgery
C G A McGREGOR,* A L MUIR, A F SMITH, H C MILLER, W J HANNAN, E W J CAMERON,
D J WHEATLEYt
From the Departments of Clinical Surgery, Medicine, Clinical Chemisny, and Medical Physics, University of
Edinburgh, and the Departments of Cardiology and Cardiac Surgery, Royal Infirmary, Edinburgh
SUMMARY Fifty consecutive patients undergoing coronary artery bypass grafting for chronic stable
angina were assessed by serial electrocardiography, preoperative and postoperative myocardial scanning
with technetium-99m pyrophosphate, gated radionuclide ventriculography, and serial measurement
of creatine kinase, aspartate aminotransferase, urea stable lactic dehydrogenase, and
creatine kinase isoenzyme (MB) to assess the incidence of perioperative myocardial infarction and
identify the most appropriate diagnostic techniques. The correlation between myocardial scanning
and the measurement of peak enzyme and isoenzyme activity was excellent in the diagnosis of
perioperative infarction, although electrocardiography proved less helpful. There appeared to be no
advantage in measuring creatine kinase MB rather than the more routinely measured enzymes.
There were two deaths and evidence of myocardial infarction in five other patients, an incidence of
14%. Perioperative infarction was associated with a significant reduction in resting ejection fraction
in two cases. In those patients without evidence of perioperative infarction the mean increase in
ejection fraction of 7.80/o was statistically significant.
Myocardial infarction related to coronary artery
bypass graft surgery is associated with increased mortality
and morbidity and accounts for most deaths
perioperatively and within the first month of operation.
‘ The incidence of this complication is difficult to
estimate, and figures of 4-40% have been reported.2-4
The varying incidence can be attributed to variations
in operative expertise, techniques of myocardial protection,
case selection, and particularly to the diagnostic
indices of myocardial infarction applied in different
series.5-7
The assessment of chest pain and interpretation of
the electrocardiogram in the diagnosis of myocardial
infarction after cardiac surgery are difficult.8-’0 An
increase in the activity of enzymes, including the rela-
Requests for reprints to Dr C G A McGregor, Department of Cardiovascular
Surgery, Stanford University School of Medicine, Stanford
University Medical Center, Stanford, California 94305, USA.
*Present address: Department of Cardiovascular Surgery, Stanford University
School of Medicine, Stanford University Medical Center, Stanford, CA 94305,
USA.
tPresent address: Department of Cardiac Surgery, University of Glasgow, Royal
Infirmary, Glasgow.
Accepted for publication 27 October 1983
tively cardiospecific MB isoenzyme of creatine kinase
(CKMB), occurs after cardiac surgery, and the ability
of plasma enzyme measurements to distinguish those
patients who have had a myocardial infarction related
to coronary surgery remains uncertain.” - ‘3 Other
diagnostic techniques include radionuclide imaging
with technetium-99m pyrophosphate, which in a
non-surgical context is a sensitive and specific indicator
of myocardial infarction.14 15 Furthermore, this
technique may be the only method of making the
diagnosis after coronary surgery in some
patients. 16- 18
Severe myocardial infarction is likely to be associated
with impairment of left ventricular function, and
a comparison of left ventricular performance before
and after operation using radionucide ventriculography
is a further method of assessing myocardial
injury.
In the present study the above techniques were
used in 50 patients undergoing coronary artery bypass
surgery. Our aim was to identify the most appropriate
techniques for diagnosing perioperative myocardial
infarction. Once the incidence of perioperative infarction
and the most accurate methods of diagnosis have
been determined, the effect of improved methods of
399
McGregor, Muir, Smith, Miller, Hannan, Cameron, Wheatley
myocardial preservation may be assessed.
Patients and methods
Fifty consecutive patients undergoing coronary artery
bypass graft surgery as the sole procedure were
studied. All underwent operation for the treatment of
chronic stable angina uncontrolled by optimum medical
treatment. All patients were being treated with
beta blockers. Their age range was 36-68 (mean 52)
years.
OPERATIVE TECHNIQUES
Standard cardiopulmonary bypass techniques were
used at flow rates of 2*4 1/M2. The mean bypass time
was 114 minutes (range 53-224 minutes), and the
mean aortic cross clamping time 36 minutes (range
0-72 minutes). The mean number of grafts performed
was 2-1 per patient (range 1-4). Intermittent aortic
cross clamping with systemic hypothermia to 28°C
was used in 24 patients and cold potassium cardioplegic
arrest with topical cardiac cooling and systemic
hypothermia to 28°C in 26. The method of myocardial
protection used was based on the current practice of
the surgeon performing the operation.
-L407
D
w
Cca7)
-
E
0 30-
c
0
C–
L-20
a)
0~
E
a
43, 10-
0
E
> l
N
c)
LLJ
ELECTROCARDIOGRAPHY
Electrocardiograms were recorded preoperatively and
daily postoperatively until discharge and were assessed
blind by a cardiologist. The appearance of new Q
waves of 0-04 s or more duration was regarded as
indicating myocardial infarction.
ENZYME MEASUREMENT
Creatine kinase and aspartate aminotransferase were
measured by standard techniques. ‘9 The upper limit
of normal for non-ambulant healthy subjects is 150
U/I and 30 U/I respectively.
Creatine kinase MB was measured using a slight
modification of the chromatographic method of
Mercer,20 using kit reagents supplied by Boehringer
Corporation, Lewes. The upper limit of normal for
non-ambulant healthy subjects is 10 U/1.
Urea stable lactate dehydrogenase was measured
using a slight modification of a previously published
method.2′ The upper limit of normal for healthy
adults is 300 U/1.
Analytical precision was 5% (coefficient of variation)
for enzyme activities for each enzyme in the
ranges encountered in this study. The above enzymes
were measured preoperatively and on seven subse-
P <0001
a
A6
P<0 001
a
a
P<0.001
a
a
A
:1
a Pc<0001
~~~~~ -Ml
Normcil
I 1-~~~’ range
CKMB CK AST USLD
Fig. 1 Peak serum enzyme activities (expressed as a multiple ofthe upper limit ofnormal)
for creatine kinase MB (CKMB), creatine kinase (CK); aspartate aminotransferase
(AS7), and urea stable lactate dehydrogenase (USLD).
A, patients with both positive myocardial scan and positive enzyme activity; 0, remainder
ofpatients. p values refer to comparison of individual enzymelisoenzyme activities between
five patients with both positive myocardial scans and positive enzymeslisoenzyme activity
and the remaining patients.
400
*0 *
Myocardial infarction related to coronary artery bypass graft surgery
quent occasions in the first 48 hours postoperatively:
immediately and at 3, 6, 9, 12, 24, and 48 hours after
operation.
STATISTICAL ANALYSIS OF DATA
The definition of a normal response of plasma enzyme
activity to coronary artery surgery is difficult. Fig. 1
shows that of the peak measurements for each enzyme
a few were higher than the rest. To obtain an objective
but, purely arbitrary, definition of normal and
abnormal increases in enzyme activity, the following
procedure was adopted for each enzyme:
(1) All enzyme values were log transformed
(since even the central and left hand portions of the
frequency distribution curves showed a log normal
rather than a normal distribution).
(2) The central symmetrical portion of the distribution
curve (trimmed) was used to yield provision
estimates of mean and standard deviation
(SD).22
(3) Means and standard deviations for each
enzyme were calculated using all enzyme measurements
except for those which were more than 2
SD above the trimmed mean (from (2)).
Any enzyme measurement more than 2 SD above
the mean was classed as being abnormally high. This
figure was 109 U/I for creatine kinase MB, 2600 U/I
for creatine kinase, 190 U/I for aspartate aminotransferase,
and 800 U/I for urea stable lactate dehydrogenase.
MYOCARDIAL SCANNING
Analogue and digital images were obtained two hours
after an intravenous injection of 400 MBq (10-8 mCi)
of technetium-99m pyrophosphate in the anterior, 300
and 600 left anterior oblique, and left lateral projections
with the patient supine using a Nuclear Enterprises
Mk 5 HR gamma camera.
Forty eight patients who were available for study
had scans performed between two and five days postoperatively,
and in 34 patients scans were also performed
preoperatively. All scans were assessed blind
by two observers and were graded into: (a) those
showing no activity (-), (b) those showing increased
activity over the region of the heart but of less intensity
than surrounding bone (+), and (c) those with
increased activity over the heart of equal or greater
intensity than bone (+). Only category (c) was
accepted as a true positive for myocardial infarction
and had to be present in two of the four views.
RADIONUCLIDE VENTRICULOGRAPHY
Radionuclide ventriculography was carried out
preoperatively and one week postoperatively at rest in
34 of the 50 patients. All studies were carried out with
patients supine using a 30° left anterior oblique projection
with a 100 caudal tilt on a Nuclear Enterprises
Mk 5 HR gamma camera. The method of analysis has
been described in detail elsewhere.23
Results
All 34 preoperative technetium myocardial scans were
negative. Preoperative enzyme activity was not
appreciably increased in any of the 50 patients. Two
deaths occurred in the immediate postoperative
period of low cardiac output. Both patients were considered
to have suffered myocardial injury at the time
of operation which was incompatible with maintaining
circulation. Of the 48 patients surviving operation,
36 had no evidence of myocardial infarction
when any of the criteria used in the study were
applied.
Table 1 shows the results for the remaining 12
patients who had evidence of myocardial infarction by
at least one criterion. Table 2 summarises the positive
Table 1 Evidence ofmyocardial infarction in 50 patients after coronary artery bypass graft(s) using technetium-99mpyrophosphate
scanning, electrocardiography, and enzyme measurements
Case No Myocardial scanning Electrocardiography Enzyme activity
CKMB CK AST USLD
1 + + + + + +
2 + + + + + _
3 + - + + + +
4 + - _ _ _ _
5 - + _ _ _ _
6 - + - - - +
7 + - + + + +
8 - - + _ _ _
9 - + _ _ _ _
10 + + + + + +
11 - - + - - -
12 - - - - + -
CKMB, creatine kinase MB; AST, aspartate aminotransferase; USLD, urea stable lactate dehydrogenase; -, negative; +, positive; +, scans
showing increased activity over-the region of the heart but of less intensity than surrounding bone.
401
McGregor, Muir, Smith, Miller, Hannan, Cameron, Wheatley
Table 2 Swmary of results of myocardial scanning, measurement ofenzme actitity, and electrocardiography in 12 patients with
evidence of myocardial infarction after coronary artmy bypass grafting
No ofpositive results ECG changes
Scans Enzymes
CKMB AST USLD Total
Myocardial sans 5 5 5 4 5 3
Electrcardiographic
changes 3 3 3 3 3 6
Enzyme measurements 5 6 4
CK, creatine kinase; AST, aspartate aminotransferase; USLD, urea stable lactate dehydrogenase.
findings of the diagnostic tests used. In Tables 2 and 3
the results in those patients with isolated increases in
activity of only one enzyme and in whom there was no
evidence of infarction by any other criterion were
omitted.
Five patients had positive myocardial scans. All five
had enzymatic evidence of infarction in at least three
of the four enzyme measurements including creatine
kinase MB isoenzyme. Three of the five patients
fulfilled the electrocardiographic criterion of infarction.
One further patient had a scan of diffuse appearance
(giving a ± result) which did not correlate with
the other criteria.
Six patients had electrocardiographic changes indicating
myocardial infarction, but in only three (the
same three as above) did this correlate with scanning
and enzymatic evidence of infarction. Six patients had
enzymatic evidence of myocardial infarction. Five of
these patients had positive scans. Four of the patients
had positive electrocardiographic evidence, but in one
(case 6) the enzymatic evidence consisted of an isolated
increase in urea stable lactate dehydrogenase
activity.
Table 3 outlines the changes in resting ejection fraction
during the operative period in those patients with
evidence of infarction. Of the five patients with both
scanning and enzymatic evidence of infarction, the
ejection fraction remained the same in three and
decreased by 0.1 and 0*18 in the remaining two
patients, the greatest reductions in the entire group.
In the two patients in this group with negative electrocardiograms
the ejection fraction decreased by 0-1
in one and was the same in the other (+0.01). The
mean reduction in ejection fraction in these patients
was 12-1%, although this was not statistically
significant compared with the preoperative value in
this small group of patients. In the two patients with
isolated positive creatine kinase MB activity and a
negative scan and negative electrocardiogram ejection
fraction increased by 0-1 and 0 12 respectively. In the
two patients with positive electrocardiograms and
both negative scan and negative enzyme/isoenzyme
activity ejection fraction increased in one and was the
same in the other. In the one patient with a positive
electrocardiogram and isolated positive urea stable
lactate dehydrogenase activity ejection fraction was
Table 3 Changes in resting ejection fraction assessed by radionuclide ventriculography in 11 patients with evidence of infarction by
myocardial scanning, measurement ofenzymatic activity, and electrocardiography
Case No Before surgery After surgery Change
Positive scans and positive enzyme activiy
1 0-49 0.5 +0-01
2 0-49 0.45 -0-04
3 0-4 0-41 +0-01
7 0-38 0.28 -0.1
10 0.59 0-41 -0-18
Positive enzyme activty, negative scans, and negative ECG
8 0-53 0-63 +0-1
11 0-4 0.52 +0-12
Positive ECG, negative scans, and negative enzyne activity
5 0-4 0-52 +0-12
9 0-4 0-44 +0-04
Positive enezye (USLD) activity, positive ECG, and negative scan
6 0-63 0-57 -0-06
Equivocal scan, negative ECG, negative enzyme activity
4 0.52 0-57 +0.05
402
Myocardial infarction related to coronary artery bypass graft surgery
0)
C,
0 3 6 9 12 24 36 48
t L Hours after discontinuation of bypass J
Before
operation
Fig. 2 Mean (geometric) activity of creatine kinase MB at
t’arious times in the postoperative period for patients with infarcts
(A) and those without (*).
reduced by 0-06. When the five patients with positive
scans and positive enzymes are excluded, there was a
significant mean increase in ejection fraction in the
remaining patients of 7.80/o in relation to preoperative
values (p<0-05). Improved detection of wall motion
abnormalities by phase analysis may be helpful in
diagnosing perioperative infarction, but this method
was not available to us at the time of the study.
Measurements of activity of each of the four
enzymes in the five patients with both positive scans
and positive enzymes were compared with those in the
remaining patients using the Mann-Whitney U test of
ranking (Fig. 1). There was no difference between the
enzymes in their ability to differentiate between these
five patients and the remainder. The timing as well as
the magnitude of creatine kinase MB release were different
in these five patients compared with those in
the remaining patients (Fig. 2). Peak creatine kinase
MB release occurred between nine and 12 hours after
operation in these five patients but at about three
hours in the others. Only creatine kinase MB has this
notable qualitative difference in the shape of the
release curve.
There was no significant difference between these
five patients with positive myocardial scans and positive
enzymes and isoenzymes activity and the remainder
of the group in age, cross clamping time, cardiopulmQnary
bypass time, number of coronary grafts
performed, or, with one exception, length of stay in
hospital.
Discussion
Myocardial infarction after coronary artery bypass
graft surgery may result from early graft closure,
technical failure, or embolisation from the site of
anastomosis or from global myocardial ischaemia
secondary to cross clamping at the aorta and inadequate
myocardial protection. Coronary artery surgery
can, therefore, result in myocardial injury which varies
in both magnitude and type-that is, whether
transmural or global or a mixture of both.
Coronary surgery may improve left ventricular
function by restoring circulation to ischaemic
myocardium but if complicated by perioperative
myocardial infarction may compromise left ventricular
function. A balance of the two effects may be present
in any individual patient. For this reason we performed
ventriculography. Our own observations in
non-surgical myocardial infarction2425 and that of
others26-28 suggest that, although left ventricular
ejection fraction may fluctuate in the acute stages
(0-24 h) of myocardial infarction, cardiac performance
thereafter changes little but, in general, gradually
improves over the next three to six months. As
the patients in the present study were haemodynamically
stable without taking any positive inotropic
agent at the time of either ejection fraction determination
it was appropriate to image at this time and use
the observation to correlate with the other diagnostic
criteria of severe myocardial injury.
The likelihood of one particular test yielding a positive
diagnosis will depend on whether the infarction is
transmural or global and on the diagnostic threshold
applied to that test. Transmural infarction is more
likely to result in a positive electrocardiogram and
myocardial scan than a more diffuse lesion, whereas
measurements of increased enzyme and isoenzyme
activity should be obtained in both. There is, therefore,
no clinical gold standard for the diagnosis of
perioperative myocardial infarction. In this study the
criteria for a positive scan were set high purposefully
to avoid false positive results, but by doing this we
may have missed very small infarcts. Although we
attempted to be objective, the enzymatic and isoenzymatic
criteria of infarction are (as discussed) arbitrary.
In this study a good correlation was found between
radionuclide scintigraphic and enzymatic and isoenzymatic
evidence of myocardial injury. All five
patients with positive myocardial scans had enzymatic
and isoenzymatic evidence of injury. Agreement between
the positive scanning and positive enzymatic
criteria applied in the study was regarded as diagnostic
of myocardial infarction, and, therefore, these five
patients were considered to have had an infarction.
In two of these patients infarction was associated
403
McGregor, Muir, Smith, Miller, Hannan, Cameron, Wheatley
with a pronounced reduction in resting ejection fraction
as assessed non-invasively by radionuclide ventriculography.
In three patients there was little change
in ejection fraction, and this is consistent with reports
questioning the functional importance of perioperative
infarction in some patients.29 30 Nevertheless, in
two cases perioperative infarction resulted in a pronounced
deterioration in cardiac function with a
reduced ejection fraction, and in one case the patient
was in hospital for three months because of low cardiac
output and subsequent renal failure. In the other
four patients with myocardial infarction hospital stay
was not prolonged. These results agree with those of
previous reports showing early and late reduction in
ventricular function in patients who have had a
perioperative myocardial infarction.3′ 32 In contrast,
those patients in the study who were not considered to
have had a perioperative infarction had a significant
increase in ejection fraction of 7-8%. It is difficult to
assess how much the withdrawal of beta blockade
affected the postoperative measurement of ejection
fraction, but some effect was present in patients both
with and without infarcts. In the two patients with
isolated isoenzymatic evidence of infarction and negative
enzymes, a negative myocardial scan, and negative
electrocardiogram no functional deterioration
occurred, and the results support the findings of
others that isoenzyme activity may be too sensitive in
assessing perioperative myocardial infarction when
used alone.3334 The one patient with an equivocal (±
result) scan had a diffuse increase in uptake over the
precordium, which was of lower intensity than that in
surrounding bone, and the importance of this appearance
is uncertain.6 15 Patients without coronary disease
may show such an appearance. Simultaneous
measurement of perioperative enzyme activity helps
to elucidate this problem. There were no positive
preoperative scans, and this may reflect the fact that
our patients had chronic stable angina. Provided that
agreement between scanning and enzymatic evidence
is accepted as proof of myocardial infarction, in this
study there were no false positive scans, which is similar
to the results of other workers.’ 33 Such patients
with chronic stable angina do not seem to need to be
studied preoperatively in contrast to other groups of
patients-that is, those with unstable angina, in
whom the incidence of positive preoperative scans
may be as high as 400/o.16 35
The measurement of peak isoenzyme activity
proved to be a valuable adjunct to myocardial scanning
in this study and has been shown to correlate
well with other indices of myocardial injury, but its
sensitivity and relative advantages over the more
commonly measured enzymes are unclear.3 3637 An
important aspect of our study was the finding that
there was no advantage in measuring creatine kinase
MB isoenzyme rather than the more routinely measured
enzymes. For our laboratory we suggest that
measurements of creatine kinase total of 2600 U/I,
aspartate aminotransferase of 190 U/1, and urea stable
lactate dehydrogenase of 800 U/I represent myocardial
infarction, although the frequency and timing of sampling
must be taken into account. These findings will
vary for different types of cardiac operations and between
centres. The time of peak activity of creatine
kinase MB in this study differed between patients
with and without infarcts, being nine to 12 hours after
operation in those with infarcts and three hours in
those without. For routine purposes, it is difficult to
justify the requirement for measuring creatine kinase
MB.
The electrocardiogram was positive in three of the
five patients with scanning and isoenzymatic evidence
of injury. Of the other three patients who developed
new Q waves, their appearance was transitory in two
and persisted in one. These findings are consistent
with previous reports of Q waves which do not persist
and false positives which have been attributed to
unmasking of old infarcts by restoring a normal circulation
to an ischaemic contralateral ventricular wall.38
Q waves also occur in patients in whom an improvement
in regional wall motion in the relevant area has
been observed,39 although others have found no evidence
that the appearance of new Q waves was not
due to myocardial infarction.3′
Many surgical considerations may affect the incidence
of perioperative myocardial infarction. In this
study both techniques of myocardial protection were
used in the group with an infarction. There was one
death and one infarct in patients in whom cold cardioplegia
was used and one death and four infarcts in
the group who had aortic cross clamping with systemic
hypothermia. In the present study there was no
relation between the incidence of perioperative
myocardial infarction and cardiopulmonary bypass
times or number of coronary grafts performed, which
agrees with some previous reports4041 but contrasts
with others.3042
As well as resulting in an increase in operative mortality
perioperative myocardial infarction has been
shown in a recent report from the Coronary Artery
Surgery Study42 to result in a significant reduction in
the three year cumulative survival rate. In that study
perioperative infarction was diagnosed by the
development of new postoperative Q waves, and these
workers acknowledge that this may represent an
underestimate of the true incidence. Accepting that
the concordance of scanning and enzymatic evidence
is indicative of myocardial infarction, the incidence of
perioperative infarction in the current study was 14%,
including the two patients who died in the immediate
postoperative period. It is crucial to estimate the inci-
404
Myocardial infarction related to coronary artery bypass graft surgery
dence of perioperative myocardial infarction in order
to assess the early and late results of coronary artery
surgery and to allow surgeons to monitor the effectiveness
of currently used methods of myocardial protection.
The combination of myocardial scanning and
the measurement of enzyme activity can give a high
degree of accuracy in this sometimes difficult diagnostic
problem.
This study was carried out with the support of
research grants from the Lothian Health Board and
Scottish Hospital Endowment Research Trust.
References
1 DePuey EG, Mathur V, Hall RJ, Burdine JA. Infarct
induced wall motion abnormalities in aortocoronary
bypass patients. Correlation with electrocardiographic,
enzymatic and scintigraphic diagnostic criteria. Cardiovascular
Diseases, Bulletin of the Texas Heart Institute
1980; 7: 382-96.
2 Mundth ED, Austen WG. Surgical measures for coronary
heart disease. N Engl J Med 1975; 293: 75-80.
3 Fennell WH, Chua KG, Cohen L, et al. Detection, prediction
and significance of perioperative myocardial
infarction following aortocoronary bypass. J Thorac Cardiovasc
Surg 1979; 78: 244-53.
4 Bulkley BH, Hutchins GM. Myocardial consequences of
coronary artery bypass graft surgery. The paradox of
necrosis in areas of revascularization. Circulation 1977;
56: 906-12.
5 Hearse DJ, Braimbridge MV, Jynge P. Protection of the
ischaemic myocardium. In: Cardioplegia. New York:
Raven Press, 1982: 376-410.
6 Balderman SC, Bhayana JN, Steinbach JJ, Musud ARZ,
Michalek S. Perioperative myocardial infarction: a diagnostic
dilemma. Ann Thorac Surg 1980; 30: 370-7.
7 Kirklin JW, Conti VR, Blackstone EH. Prevention of
myocardial damage during cardiac operations. N Engl J
Med 1979; 301: 135-41.
8 Righetti A, Crawford MH, O’Rourke RA, et al. Detection
of peri-operative myocardial damage after coronary
artery bypass graft surgery. Circulation 1977; 55: 173-8.
9 Kansal S, Roitman D, Kouchoukos N, Sheffield LT.
Ischemic myocardial injury following aortocoronary
bypass surgery. Chest 1975; 67: 20-7.
10 Schroeder JS, Alderman EL, Harrison DC. Perioperative
myocardial infarction during cardiac surgery:
diagnosis, ECG and enzyme testing. Adv Cardiol 1975;
15: 179-84.
11 Voegele LD, Gross AJ, Prioleau WM, Hairston P.
Application of multivariate analysis to the enzyme patterns
in the serum of patients undergoing coronary artery
operation. Ann Thorac Surg 1980; 29: 444 50.
12 Strom S. Prognostic significance of cardiopulmonary
bypass time and postoperative serum enzyme levels in
coronary surgery. Scand J Thorac Cardiovasc Surg 1979;
13: 133-8.
13 Van der Laarse A, Davids HA, Hollaar L, Van der Valk
EJM, Witteveen SAGJ, Hermens WT. Recognition and
quantification of myocardial injury by means of plasma
enzyme and isoenzyme activities after cardiac surgery. Br
Heart J 1979; 41: 660-7.
14 Willerson JT, Parkey RW, Bonte FJ, Lewis SE, Corbett
J, Buja LM. Pathophysiologic considerations and clinicopathological
correlates of technetium 99m stannous
pyrophosphate myocardial scintigraphy. Semin Nucl Med
1980; 10: 54-69.
15 Lyons, KP, Olson MG, Aronow WS. Pyrophosphate
myocardial imaging. Semin Nucl Med 1980; 10: 168-77.
16 Klausner SC, Botvinick EH, Shames D, et al. The application
of radionuclide infarct scintigraphy to diagnose
peroperative myocardial infarction following revascularization.
Circulation 1977; 56: 173-81.
17 Burdine JA, DePuey EG, Orzan F, Mathur VS, Hall RJ.
Scintigraphic, electrocardiographic, and enzymatic diagnosis
of perioperative myocardial infarction in patients
undergoing myocardial revascularization. J Nucl Med
1979-, 20: 711-9.
18 Righetti A, O’Rourke RA, Schelbert H, et al. Usefulness
of pre-operative and postoperative Tc99m (Sn)
pyrophosphate scans in patients with ischemic and valvular
heart disease. Am J Cardiol 1977; 39: 43-9.
19 The Committee on Enzymes of the Scandinavian Society
for Clinical Chemistry and Clinical Physiology. Recommended
method for the determination of creatine kinase
in blood. Scand J Clin Lab Invest 1976; 36: 711-23.
20 Mercer DW. Separation of tissue and serum creatine
kinase isoenzymes by ion exchange chromatography.
Clin Chem 1974; 20: 36-40.
21 Brydon WG, Smith AF. An appraisal of routine methods
for the determination of the anodal isoenzymes lactate
dehydrogenase. Clin Chim Acta 1973; 43: 361-9.
22 Healy MJR. Outliers in clinical chemistry quality control
schemes. Clin Chem 1979; 25: 675-7.
23 Muir AL, Hannan WJ, Sapru RP, Boardman AK,
Wraith PK, Brash HM. The effects of isoprenaline,
atropine and dobutamine on ventricular volume curves
obtained by radionuclide ventriculography. Clin Sci
1980; 58: 357-64.
24 Dewhurst NG, Hannan WJ, Muir AL. Prognostic values
of radionuclide ventriculography after myocardial infarction.
Q J Med 1980; 49: 479-90.
25 Dewhurst NG, Muir AL. Comparative prognostic value
of radionuclide ventriculography at rest and during exercise
in 100 patients after first myocardial infarction. Br
HeartJ 1983; 49: 111-21.
26 Wackers FJ, Berger HJ, Weinberg MA, Zaret BL. Spontaneous
changes in left ventricular function over the first
24 hours of acute myocardial infarction: implications for
evaluating early therapeutic interventions. Circulation
1982; 66: 748-54.
27 Borer JS, Rosing DR, Miller RH, et al. Natural history
of left ventricular function during one year after acute
myocardial infarction. Comparison with clinical, electrocardiographic
and biochemical determinations. Am J
Cardiol 1980; 46: 1-12.
28 Schelbert HR, Henning H, Ashburn WL, Verba JW,
Karliner JS, O’Rourke RA. Serial measurements of left
ventricular ejection fraction by radionuclide angiography
early and late after myocardial infarction. Am J Cardiol
1976; 38: 407-15.
29 Spencer FC. The significance of myocardial preservation
405
McGregor, Muir, Smith, Miller, Hannan, Cameron, Wheatley
and subclinical myocardial infarction following coronary
bypass. Ann Thorac Surg 1978; 26: 197-203.
30 Espinoza J, Lipski J, Litwak R, Donoso E, Dack S. New
Q waves after coronary bypass surgery for angina pectoris.
Am J Cardiol 1974; 33: 221-2.
31 Sternberg L, Wisneski JA, Ullyot DJ, Gertz EW.
Significance of new Q waves after aortocoronary bypass
surgery. Circulation 1975; 52: 1037-44.
32 Dawson JT, Hall RJ, Garcia E, Cooley DA. Myocardial
infarction after coronary artery bypass (CAB) surgery
[Abstract]. Circulation 1972; 46 (suppl II): II 144.
33 Raabe DS Jr, Morise A, Sbarbaro JA, Gundel WD.
Diagnostic criteria for acute myocardial infarction in
patients undergoing coronary artery bypass surgery. Circulation
1980; 62: 869-78.
34 Coleman RE, Klein MS, Roberts R, Sobel BE. Improved
detection of myocardial infarction with Technetium 99m
stannous pyrophosphate and serum MB creatine phosphokinase.
Am J Cardiol 1976; 37: 732-5.
35 Karunaratne HB, Walsh WF, Fill HR, Resnekov L,
Harper PV. Technetium 99m pyrophosphate myocardial
scintigraphy in patients with chest pain. Lack of diagnostic
specificity [Abstract]. J Nucl Med 1976; 17: 523-4.
36 Gray RJ, Shell WE, Conklin C, et al. Quantification of
myocardial injury during coronary artery bypass graft.
Circulation 1978; 58 (suppl I): 38-42.
37 Klein MS, Coleman RE, Weldon CS, Sobel BE, Roberts
R. Concordance of electrocardiographic and scintigraphic
criteria of myocardial injury after cardiac
surgery. J Thorac Cardiovasc Surg 1976; 71: 934-7.
38 Bassan MM, Oatfield R, Hoffman I, Matloff J, Swan
HJC. New Q waves after aortocoronary bypass surgery.
Unmasking of an old infarction. N Engl J Med 1974;
290: 349-53.
39 Aintablain A, Hamby RI, Hoffman I, Weisz D, Voleti C,
Wisoff BG. Significance of new Q waves after bypass
grafting: correlation between graft patency ventriculogram
and surgical venting techniques. Am HeartJ3 1978;
95: 429-40.
40 Baur MR, Peterson TA, Arnar V, Gannon PG, Gobel
FL. Predictors of perioperative myocardial infarction in
coronary artery operation. Ann Thorac Surg 1981; 31:
36-44.
41 Langou RA, Wiles JC, Peduzzi PN, Hammond GL,
Cohen LS. Incidence and mortality of perioperative
myocardial infarction in patients undergoing coronary
artery bypass grafting. Circulation 1977; 56 (suppl II):
54-8.
42 Chaitman BR, Alderman EL, Sheffield LT, et al. Use of
survival analysis to determine the clinical significance of
new Q waves after coronary bypass surgery. Circulation
1983; 67: 302-9.

Heart misdiagnosis fine $776,000

admin | December 10, 2009

A SYDNEY GP who misdiagnosed a patient suffering serious heart disease has been ordered to pay him $776,000 in damages.

Self-employed Sydney truck driver Kevin George first visited his general practitioner, Dr Hafizur Survery, on June 12, 2003 for advice and treatment for chest pains.

A little over a month later he underwent emergency heart surgery, which left the 57-year-old unable to work and with a life expectancy of only two years.

He has since undergone a life-prolonging heart transplant operation.

In the NSW Supreme Court on Wednesday, Dr Survery was ordered to pay Mr George $776,095, plus court costs, for failing to properly diagnose his condition.

Intravascular ultrasound guided PTCA: a way to escape

admin | December 10, 2009

European Heart Journal (2000) 21, 92–94
Article No. euhj.1999.1892, available online at http://www.idealibrary.com on
Editorials
Intravascular ultrasound guided PTCA: a way to escape
stent mania?
See page 137 for the article to which this Editorial
refers
In 1995, a total of 278 982 percutaneous coronary
interventions were carried out in Europe alone[1]. In
the United States, the corresponding figure for the
same period was approximately 500 000, and these
figures continue to increase worldwide, year after
year. To date, plain old balloon angioplasty remains
the strategy of choice in the majority of cases, even
though a myriad of different devices have been conceived,
developed and tested in percutaneous coronary
interventions. However, up to now, no other
single device has seen the same spectacular explosion
on the market as the stent, and none has managed to
oust the angioplasty balloon from its position at the
top of the polls.
Introduced in 1986, stents spread relatively slowly
until the publication of large multicentre trials demonstrating
the efficacy of this device in the prevention
of restenosis[2,3]. Since then, stents have spread like
wildfire, and their diffusion has been all the more
encouraged by improvements in the prevention of
subacute occlusions. In 1997, the average rate of
stenting in Europe was 51%, with figures ranging
from 25% in Eastern Europe to more than 60% in
Western European nations[4]. Since this report was
compiled, the rate of stenting has continued to grow,
and is probably around 70% now.
The most common indications for stenting are
abrupt vessel closure, suboptimal result defined by
residual stenosis >30%, coronary dissection of grade
C or higher and treatment of restenosis on a native
artery, not to mention the very broad indications for
stenting in veinous bypass grafts. Without a doubt,
stenting makes it possible to control abrupt occlusions
and to optimize the result of the conventional
angioplasty procedure. In short, the stent has made
angioplasty safer and easier, with improved immediate
results. However, it is worth noting that all these
indications for stenting are based on observational
studies only. The only indication in which the efficacy
of stents has been proven is still complied with
relatively rarely, namely the prevention of restenosis
in STRESS-BENESTENT-type lesions, i.e. in lesions
less than 15 mm in length, and in arteries with a
diameter >2·8 mm and <3·5 mm[4].
Furthermore, it would appear that stenting is
becoming systematic in certain centres, irrespective of
vessel size —large or small, irrespective of the final
result after conventional angioplasty, and the aspect
of the lesion site —dissected or not, dissection with
limited or non-limited flow. Direct stenting is the
other representative example of growing stent-mania.
This consists in deliberate stent deployment as the
primary treatment, without previous dilation of the
vessel, in the hope of reducing both the risk of vessel
trauma and of dissection.
All in all, the attitude of extensive stenting prevails
today despite the fact that it has never been demonstrated
that stenting reduces immediate complications
after angioplasty[2,3]. In particular, stents have never
been shown to reduce the rate of post-procedure
minor enzyme release, the prognosis of which is
uncertain[5]. Widespread stenting persists, despite the
considerable cost induced by their mass use, and
despite the risk of intra-stent restenosis, which is
estimated to be around 25%, and for which no
satisfactory solution has yet been found[6].
In this context, the article by Schroeder et al.[7] in
this issue, in which they analyse the immediate and
long-term evolution of arterial dissections after intravascular
ultrasound guided PTCA, provides us with
an alternative view of angioplasty in the age where
the stent is king. Does their view focus on the past, or
look to the future? One must not forget the limitations
of this paper, which presents the experience
of a single centre in a non-randomized study. Intravascular
ultrasound represents a major advance in
coronary imaging because it allows a very precise
picture of the exact size of the lumen, and also of the
vessel structure, plaque burden and presence of calcification.
So far, intravascular ultrasound imaging
has been principally used to optimize stent deployment[
8–10], and to demonstrate the reality of arterial
remodelling post-angioplasty[11]. It has now become
an indispensable tool for the analysis of the intimal
mechanisms of endoluminal coronary interventions.
0195-668X/00/020092+12 $35.00/0  2000 The European Society of Cardiology
Moreover, recent studies would tend to prove that
intravascular ultrasound allows for a physiological
approach to coronary flow[12]. Furthermore, Abizaid
et al. have shown that a stenosis is not haemodynamically
significant when the cross-sectional area
of the narrowing is >4 mm2[13]. Using intravascular
ultrasound to guide angioplasty offers the possibility
of optimizing balloon size by adapting it to the real
diameter of the artery as measured from external
elastic lamina to external elastic lamina, and not
according to the vascular lumen size as is the case in
quantitative angiography. This results in a balloon/
artery ratio considerably greater than 1, and is probably
one of the reasons why residual stenosis of <30%
at the end of the procedure, a so-called ‘stent like
result’ can be more frequently obtained with intravascular
ultrasound guided PTCA than in traditional
angiography guided PTCA. Contrary to previous
reports stating that oversizing resulted in more
frequent complications, the rate of major adverse
cardiac events in this report does not seem to be
increased compared to conventional balloon angioplasty
without oversizing[14]. Finally, intravascular
ultrasound also allows for a close analysis of dissection,
and shows that these latter are in fact very
common, occurring in more than two-thirds of all
cases of angioplasty. This confirms that dissections
are an integral part of the mechanism of action of
angioplasty.
The article by Schroeder et al.[7] shows above all
that the evolution of non-stented arterial dissections,
provided they are not flow-limiting, is favourable in
the majority of cases, with the rate of major adverse
cardiac events in this series not exceeding that
attained in other series with extensive stenting. This
result seems to be achievable thanks to significant
over-sizing of the balloon compared to the
angiography-determined lumen size, resulting in
major enlargement of lumen size so that arterial
dissections do not compromise the flow. The final
result is that the rate of the stenting in this series will
probably be considered by most interventional cardiologists
as being ridiculously low, at less than 5%. In
addition, the long-term evolution indicates that a low
restenosis rate can be achieved without the use of
stents. Of course, to be validated, these results need to
be confirmed by further studies, and reproduced by
other investigators.
All in all, intravascular ultrasound is one of the
tools developed for and by angioplasty, but which did
not experience the same widespread use as some of
the other devices at the disposal of interventional
cardiologists. This lack of popularity is most likely
due to the relatively high price of the intravascular
ultrasound consoles which are necessary to operate
the probes, and of course, the price of the actual
intravascular ultrasound catheter itself, even though
this latter is still considerably cheaper than a stent.
In addition, the use of intravascular ultrasound
increases the complexity of the procedure, whereas
stent implantation results in over-simplification
of the procedure, and increased comfort for the
physician, explaining the relative lack of interest by
interventional cardiologists in this imaging technique.
In any case, this article clearly shows that angioplasty
carried out in a different way, with the choice
of balloon size guided by accurate intravascular
ultrasound measurement of vessel size, makes it
possible to achieve results which compare favourably
with systematic stenting. The time has come to carry
out further, randomized studies in this area. Some
are already ongoing in Europe. It remains to be
seen whether it is possible to escape from the
‘pense´e unique’ that coronary angioplasty must
systematically involve stent implantation.
J.-P. BASSAND
University Hospital Saint-Jacques,
Besanc¸on, France
References
[1] Windecker S, Maier-Rudolph W, Bonzel T et al. on behalf of
the Working Group Coronary Circulation of the European
Society of Cardiology. Interventional cardiology in Europe
1995. Eur Heart J 1999; 20: 484–95.
[2] Fischman DL, Leon MB, Baim DS et al. Stent Restenosis
Study Investigators. A randomized comparison of coronarystent
placement and balloon angioplasty in treatment of
coronary artery disease (STRESS trial). N Engl J Med 1994;
331: 496–501.
[3] Serruys P, De Jaegere P, Kiemenij F et al. Benestent Study
Group. A comparison of balloon-expandable-stent implantation
with balloon angioplasty in patients with coronary heart
disease. N Engl J Med 1994; 331: 489–95.
[4] Eeckhout E, Wijns W, Meier B, Goy JJ on behalf of the
members of the Working Group on Coronary Circulation of
the European Society of Cardiology. Indications for intracoronary
stent placement: the European view. Eur Heart J
1999; 20: 1014–9.
[5] Simoons ML, van den Brand M, Lincoff M et al. Minimal
myocardial damage during coronary intervention is associated
with impaired outcome. Eur Heart J 1999; 20: 1112–9.
[6] Kasaoka S, Tobis J, Akiyama T et al. Angiographic and
intravascular ultrasound predictors of in-stent restenosis.
J Am Coll Cardiol 1998; 32: 1630–5.
[7] Schroeder S, Baumbach A, Mahrholdt H. The impact of
untreated coronary dissections on the acute and long-term
outcome after intravascular ultrasound guided PTCA. Eur
Heart J 2000; 21: 137–45.
[8] Colombo A, Hall P, Nakamura S et al. Intracoronary stenting
without anticoagulation accomplished with intravascular
ultrasound guidance. Circulation 1995; 91: 1676–88.
[9] de Jaegere P, Mudra H, Figulia H et al. Intravascular Ultrasound
guided optimized stent deployment. Immediate and 6
months clinical and angiographic results from the Multicenter
ultrasound Stenting in Coronaries Study (MUSIC). Eur Heart
J 1998; 19: 1214–23.
Editorials 93
Eur Heart J, Vol. 21, issue 2, January 2000
[10] Schiele F, Meneveau N, Vuillemenot A et al. Impact of IVUS
guidance in stent deployment on 6 month restenosis rate. A
multicenter randomized study comparing two strategies, with
and without IVUS guidance. J Am Coll Cardiol 1998; 32:
320–8.
[11] Mintz GS, Popma JJ, Pichard AD et al. Arterial remodeling
after coronary angioplasty: a serial intravascular ultrasound
study. Circulation 1996; 94: 35–43.
[12] Takagi A, Tsurumi Y, Ishii Y, Suzuki K, Kawana M,
Kasanuki H. Clinical potential of intravascular ultrasound for
physiological assessment of coronary stenosis. Relationship
between quantitative ultrasound tomography and pressderived
fractional flow reserve. Circulation 1999; 100: 250–5.
[13] Abizaid A, Mintz G, Mehran R et al. Long-term follow-up
after percutaneous transluminal coronary angioplasty was
not performed based on intravascular ultrasound findings.
Importance of Lumen Dimensions. Circulation 1999; 100:
256–61.
[14] Roubin GS, Doublas JS Jr, King SB et al. Influence of balloon
size on initial success, acute complications, and restenosis
after percutaneous transluminal coronary angioplasty. A
prospective randomized study. Circulation 1988; 78: 557–65.
European Heart Journal (2000) 21, 94–96
Article No. euhj.1999.1669, available online at http://www.idealibrary.com on
Diagnosing primary diastolic heart failure
With the increasing refinement of methods to uncover
early phases of cardiac failure, we have, over the past
two decades, witnessed the emergence of diastolic
dysfunction and diastolic failure of the heart as
separate, widely recognized clinical entities. Whereas
the majority of the conditions related to diastolic
dysfunction and failure are the mere consequence of
systolic cardiac failure, there also exists a distinct
primary form of diastolic failure. Primary diastolic
failure has been commonly defined as a condition
with classic findings of congestive heart failure
with normal ventricular systolic function, but with
predominantly diastolic dysfunction. It has been
observed in a large variety of clinical conditions and
was believed to occur more commonly—at least in
the elderly population—than previously thought,
accounting for about 30% to 40% of all patients with
congestive heart failure.
In an excellent review, Vasan et al.[1] surveyed 31
studies on diastolic failure published in the period
January 1970–March 1995. From their critical analysis,
the authors were astonished to find that the
prevalence of primary diastolic heart failure, i.e.
patients with congestive heart failure and normal
ventricular systolic performance, varied widely from
13% to 74%. Despite the many possible causes, interpretations
and warnings suggested by these authors,
it is surprising that their conclusions were not taken
more seriously. Similar criticisms were recently raised
by Caruana et al.[2]. In a Letter to the Editor in
the European Heart Journal (20/5), Caruana et al.
responded to a report entitled ‘How to diagnose
diastolic heart failure’ by the European Study Group
on Diastolic Heart Failure[3]. In the Working Group’s
Report, it was stated that a diagnosis of primary
diastolic heart failure requires three obligatory conditions
to be satisfied simultaneously: (1) presence of
signs or symptoms of congestive heart failure; (2)
presence of normal or only mildly abnormal left
ventricular systolic function; (3) evidence of abnormal
left ventricular relaxation, filling, diastolic distensibility
or diastolic stiffness. Using echocardiographic
examination in patients with dyspnoea but no apparent
left ventricular systolic dysfunction, Caruana
et al. observed a prevalence of primary diastolic
dysfunction of 3–5% when using an E/A ratio in
association with deceleration time, but of 27% if
isovolumic ventricular relaxation time was used.
There was poor overlap between subjects found to be
‘abnormal’ by each of the two different criteria, with
only 2–3% when both indices were combined. From
this, the authors concluded (i) that different measures
of diastolic dysfunction give different prevalences
of primary diastolic failure, and (ii) that there is
no simple echocardiographic means of reliably
diagnosing diastolic dysfunction.
As previously stated by Vasan et al.[1], only two
reasons could possibly account for this somewhat
absurd wide variation in clinical prevalence of primary
diastolic heart failure. Either there is no agreement
of what should be considered as near-normal
systolic function and how it should be measured, or
there is no clear, generally agreed definition of diastolic
dysfunction or failure. Moreover, as many conditions
may clinically resemble primary diastolic
failure, one should first exclude all non-cardiac causes
94 Editorials
 2000 The European Society of Cardiology

Holidays, stress and hearts discussed by local cardiologist

admin | December 5, 2009

Holidays, stress and hearts discussed by local cardiologist
——————————————————————————–
Loading multimedia…
Photos

——————————————————————————–

ED BLOCHOWIAK
Dr. Sudhir Gupta, cardiologist, left, explains the technique of ECP therapy with the assistance of Susan Williams, licensed practical nurse.

By Johnna Ray
johnna.ray@news-star.com
Posted Nov 28, 2009 @ 10:11 PM

Cardiac Care Options

Treatment
Cost
Invasive?
CABG
$$$$$
Yes
TMR
$$$$
Yes
Angio/Stent
$$$$
Yes
Medicine
$$
No
ECP
$
No
Rehab
$
No

For more information about each cardiac treatment please click on each treatment title or one of the tabs at the top of the page.

 


VascuFlo, Inc.

The EECP Heart Centers
"Unlocking Your Heart's Natural Bypass"
(716) 681-2968
________


VascuScript
"Reliable - Professional - Honest"
(716) 681-2968
________


External Counterpulsation Research Foundation
Dedicated to the advancement and expanding the use of External Counterpulsation therapy.
(716) 681-2968
________


Vascuvision
________